This inventor holds 1 USPTO granted patent. Top assignee: Wuhan University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Jiasheng Liu in Abnormal Cell Recognition
Introduction
Jiasheng Liu is an accomplished inventor based in Wuhan, China. He has made significant contributions to the field of medical technology, particularly in the area of cell recognition. His innovative approach aims to enhance the accuracy and efficiency of identifying abnormal cells, which is crucial for early disease detection.
Latest Patents
Jiasheng Liu holds a patent for an "Automatic abnormal cell recognition method based on image splicing." This method involves several steps, including scanning a slide with a digital pathological scanner to obtain a cytological slide image. It utilizes a feature fusion-based localization method to automatically identify the nuclei of all cells in the image. The process further includes obtaining cell square region of interest (ROI) images, grouping these images based on sampling, and classifying them using a trained deep neural network. This innovative method allows for the simultaneous recognition of cells classified as abnormal.
Career Highlights
Jiasheng Liu is affiliated with Wuhan University, where he continues to advance his research and development in medical imaging technologies. His work has the potential to significantly impact the field of pathology by improving diagnostic processes.
Collaborations
Jiasheng Liu collaborates with notable colleagues, including Juan Liu and Zhuoyu Li. Their combined expertise contributes to the advancement of innovative solutions in cell recognition and medical diagnostics.
Conclusion
Jiasheng Liu's contributions to the field of abnormal cell recognition exemplify the importance of innovation in medical technology. His patented method showcases the potential for improved diagnostic accuracy, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
